bid:	$1.20
ask:	$1.60
(RTS Stock Exchange, 11am, 30.01.12)

Veropharm

OJSC “VEROPHARM” is the leading Russian pharmaceutical producer known in our country and abroad as one of the largest Russian pharmaceutical generic producers (analogues of well known patented medicines), as well as oncology drugs and medical plasters. OJSC “VEROPHARM” consolidated sales in 2008 amounted more than 172 million dollars.

The market strategy of the company is to constantly increase market share by rapid development of the product portfolio with high level of differentiation in the most lucrative market segments while retaining high economic effectiveness. The product portfolio currently consists of more than 400 items. A broad network of medical representatives promote VEROPHARM medicines through hospitals and pharmacies increasing VEROPHARM  brand recognition and loyalty CIS-wide.

The Company’s production facilities comprise 3 pharmaceutical plants in Belgorod, Voronezh and Pokrov; it is certificated by the WHO under GMP standards in 2003 and ISO 9001. Today these facilities have the total annual production capacity of 625 million tablets and capsules, 10 million ampoules, 468 million plasters, and 40 million vials.

Over 2000 qualified employees work in the company.

According to the Pharmexpert research agency, VEROPHARM ranks 5th in terms of output among domestic manufacturers. According to IMS, in 2008 the Company is ranked 4th on list of top ten manufacturers of oncological medications. VEROPHARM  kept its leadership positions in the rating compiled using the manufacturers of oncological medications in kind.

More information available on http://www.veropharm.ru